Logo image of EXK

ENDEAVOUR SILVER CORP (EXK) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:EXK - CA29258Y1034 - Common Stock

9.4 USD
-0.4 (-4.08%)
Last: 12/31/2025, 7:28:49 PM
9.4381 USD
+0.04 (+0.41%)
After Hours: 12/31/2025, 7:28:49 PM
Fundamental Rating

3

Taking everything into account, EXK scores 3 out of 10 in our fundamental rating. EXK was compared to 156 industry peers in the Metals & Mining industry. EXK has a bad profitability rating. Also its financial health evaluation is rather negative. EXK is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year EXK has reported negative net income.
EXK had a positive operating cash flow in the past year.
Of the past 5 years EXK 4 years were profitable.
EXK had a positive operating cash flow in each of the past 5 years.
EXK Yearly Net Income VS EBIT VS OCF VS FCFEXK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

With a Return On Assets value of -9.27%, EXK is not doing good in the industry: 71.15% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -18.53%, EXK is doing worse than 69.23% of the companies in the same industry.
EXK has a Return On Invested Capital (0.08%) which is in line with its industry peers.
EXK had an Average Return On Invested Capital over the past 3 years of 2.76%. This is significantly below the industry average of 13.25%.
Industry RankSector Rank
ROA -9.27%
ROE -18.53%
ROIC 0.08%
ROA(3y)-0.51%
ROA(5y)0.76%
ROE(3y)-0.98%
ROE(5y)0.74%
ROIC(3y)2.76%
ROIC(5y)N/A
EXK Yearly ROA, ROE, ROICEXK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

EXK has a Operating Margin (0.23%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of EXK has declined.
EXK has a Gross Margin of 13.03%. This is comparable to the rest of the industry: EXK outperforms 43.59% of its industry peers.
In the last couple of years the Gross Margin of EXK has declined.
Industry RankSector Rank
OM 0.23%
PM (TTM) N/A
GM 13.03%
OM growth 3Y-2.72%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5YN/A
EXK Yearly Profit, Operating, Gross MarginsEXK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so EXK is destroying value.
Compared to 1 year ago, EXK has more shares outstanding
The number of shares outstanding for EXK has been increased compared to 5 years ago.
EXK has a worse debt/assets ratio than last year.
EXK Yearly Shares OutstandingEXK Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
EXK Yearly Total Debt VS Total AssetsEXK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 3.03 indicates that EXK is not in any danger for bankruptcy at the moment.
EXK's Altman-Z score of 3.03 is in line compared to the rest of the industry. EXK outperforms 46.15% of its industry peers.
EXK has a Debt/Equity ratio of 0.23. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.23, EXK is in line with its industry, outperforming 45.51% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Altman-Z 3.03
ROIC/WACC0.01
WACC9.31%
EXK Yearly LT Debt VS Equity VS FCFEXK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

A Current Ratio of 0.79 indicates that EXK may have some problems paying its short term obligations.
With a Current ratio value of 0.79, EXK is not doing good in the industry: 91.03% of the companies in the same industry are doing better.
A Quick Ratio of 0.57 indicates that EXK may have some problems paying its short term obligations.
With a Quick ratio value of 0.57, EXK is not doing good in the industry: 87.82% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.79
Quick Ratio 0.57
EXK Yearly Current Assets VS Current LiabilitesEXK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

6

3. Growth

3.1 Past

The earnings per share for EXK have decreased strongly by -66.67% in the last year.
EXK shows a strong growth in Revenue. In the last year, the Revenue has grown by 49.22%.
EXK shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.33% yearly.
EPS 1Y (TTM)-66.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.71%
Revenue 1Y (TTM)49.22%
Revenue growth 3Y9.6%
Revenue growth 5Y12.33%
Sales Q2Q%167.26%

3.2 Future

The Earnings Per Share is expected to grow by 53.69% on average over the next years. This is a very strong growth
Based on estimates for the next years, EXK will show a very strong growth in Revenue. The Revenue will grow by 39.07% on average per year.
EPS Next Y-13.62%
EPS Next 2Y203.95%
EPS Next 3Y116.02%
EPS Next 5Y53.69%
Revenue Next Year106.87%
Revenue Next 2Y84.24%
Revenue Next 3Y58.14%
Revenue Next 5Y39.07%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EXK Yearly Revenue VS EstimatesEXK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M
EXK Yearly EPS VS EstimatesEXK Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.2 -0.2 0.4 0.6

2

4. Valuation

4.1 Price/Earnings Ratio

EXK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
EXK is valuated correctly with a Price/Forward Earnings ratio of 16.23.
EXK's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. EXK is cheaper than 62.18% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.13. EXK is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 16.23
EXK Price Earnings VS Forward Price EarningsEXK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EXK is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 54.68
EXK Per share dataEXK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

EXK's earnings are expected to grow with 116.02% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y203.95%
EPS Next 3Y116.02%

0

5. Dividend

5.1 Amount

EXK does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ENDEAVOUR SILVER CORP

NYSE:EXK (12/31/2025, 7:28:49 PM)

After market: 9.4381 +0.04 (+0.41%)

9.4

-0.4 (-4.08%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)11-07 2025-11-07/bmo
Earnings (Next)03-09 2026-03-09/amc
Inst Owners55.62%
Inst Owner Change18.96%
Ins Owners0.16%
Ins Owner ChangeN/A
Market Cap2.77B
Revenue(TTM)337.14M
Net Income(TTM)-94.29M
Analysts80
Price Target10.73 (14.15%)
Short Float %6.7%
Short Ratio1.47
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-354.6%
Min EPS beat(2)-595.05%
Max EPS beat(2)-114.14%
EPS beat(4)1
Avg EPS beat(4)-1434.73%
Min EPS beat(4)-5248.51%
Max EPS beat(4)218.79%
EPS beat(8)2
Avg EPS beat(8)-1023.35%
EPS beat(12)2
Avg EPS beat(12)-714.54%
EPS beat(16)3
Avg EPS beat(16)-577.87%
Revenue beat(2)2
Avg Revenue beat(2)8.49%
Min Revenue beat(2)0.04%
Max Revenue beat(2)16.94%
Revenue beat(4)3
Avg Revenue beat(4)0.1%
Min Revenue beat(4)-16.69%
Max Revenue beat(4)16.94%
Revenue beat(8)7
Avg Revenue beat(8)2.97%
Revenue beat(12)9
Avg Revenue beat(12)1.92%
Revenue beat(16)10
Avg Revenue beat(16)-0.39%
PT rev (1m)5.07%
PT rev (3m)54.94%
EPS NQ rev (1m)0%
EPS NQ rev (3m)53.33%
EPS NY rev (1m)-325%
EPS NY rev (3m)-357.14%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.09%
Revenue NY rev (1m)5.52%
Revenue NY rev (3m)10.75%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 16.23
P/S 8.2
P/FCF N/A
P/OCF 58.86
P/B 5.43
P/tB 5.43
EV/EBITDA 54.68
EPS(TTM)-0.15
EYN/A
EPS(NY)0.58
Fwd EY6.16%
FCF(TTM)-0.44
FCFYN/A
OCF(TTM)0.16
OCFY1.7%
SpS1.15
BVpS1.73
TBVpS1.73
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -9.27%
ROE -18.53%
ROCE 0.1%
ROIC 0.08%
ROICexc 0.08%
ROICexgc 0.08%
OM 0.23%
PM (TTM) N/A
GM 13.03%
FCFM N/A
ROA(3y)-0.51%
ROA(5y)0.76%
ROE(3y)-0.98%
ROE(5y)0.74%
ROIC(3y)2.76%
ROIC(5y)N/A
ROICexc(3y)3.56%
ROICexc(5y)N/A
ROICexgc(3y)3.56%
ROICexgc(5y)N/A
ROCE(3y)3.5%
ROCE(5y)N/A
ROICexgc growth 3Y-31.89%
ROICexgc growth 5YN/A
ROICexc growth 3Y-31.88%
ROICexc growth 5YN/A
OM growth 3Y-2.72%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5YN/A
F-Score3
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Debt/EBITDA 2.06
Cap/Depr 321.73%
Cap/Sales 52.32%
Interest Coverage 0.06
Cash Conversion 84.51%
Profit Quality N/A
Current Ratio 0.79
Quick Ratio 0.57
Altman-Z 3.03
F-Score3
WACC9.31%
ROIC/WACC0.01
Cap/Depr(3y)485.81%
Cap/Depr(5y)353.29%
Cap/Sales(3y)66.44%
Cap/Sales(5y)50.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-66.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.71%
EPS Next Y-13.62%
EPS Next 2Y203.95%
EPS Next 3Y116.02%
EPS Next 5Y53.69%
Revenue 1Y (TTM)49.22%
Revenue growth 3Y9.6%
Revenue growth 5Y12.33%
Sales Q2Q%167.26%
Revenue Next Year106.87%
Revenue Next 2Y84.24%
Revenue Next 3Y58.14%
Revenue Next 5Y39.07%
EBIT growth 1Y-91.44%
EBIT growth 3Y6.61%
EBIT growth 5YN/A
EBIT Next Year123.81%
EBIT Next 3Y140.25%
EBIT Next 5Y52.95%
FCF growth 1Y-134.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-5.01%
OCF growth 3Y-6.61%
OCF growth 5YN/A

ENDEAVOUR SILVER CORP / EXK FAQ

What is the ChartMill fundamental rating of ENDEAVOUR SILVER CORP (EXK) stock?

ChartMill assigns a fundamental rating of 3 / 10 to EXK.


What is the valuation status of ENDEAVOUR SILVER CORP (EXK) stock?

ChartMill assigns a valuation rating of 2 / 10 to ENDEAVOUR SILVER CORP (EXK). This can be considered as Overvalued.


How profitable is ENDEAVOUR SILVER CORP (EXK) stock?

ENDEAVOUR SILVER CORP (EXK) has a profitability rating of 2 / 10.


Can you provide the financial health for EXK stock?

The financial health rating of ENDEAVOUR SILVER CORP (EXK) is 2 / 10.


What is the expected EPS growth for ENDEAVOUR SILVER CORP (EXK) stock?

The Earnings per Share (EPS) of ENDEAVOUR SILVER CORP (EXK) is expected to decline by -13.62% in the next year.